KASTRUP TANDKLINIK ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  2.4% 1.4% 1.6% 0.9% 1.3%  
Credit score (0-100)  65 78 74 88 78  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.0 12.6 3.4 145.3 18.1  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  1,232 1,439 1,319 1,871 1,429  
EBITDA  -227 135 29.0 278 62.3  
EBIT  -250 114 4.3 248 18.6  
Pre-tax profit (PTP)  -259.4 127.3 -40.5 217.9 2.0  
Net earnings  -204.0 99.3 -27.4 164.1 -1.0  
Pre-tax profit without non-rec. items  -259 127 -40.5 218 2.0  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  27.2 30.3 129 99.9 268  
Shareholders equity total  981 1,025 941 1,048 988  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,519 1,593 1,408 1,854 1,644  

Net Debt  -964 -1,023 -866 -1,411 -1,006  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,232 1,439 1,319 1,871 1,429  
Gross profit growth  -21.9% 16.8% -8.3% 41.8% -23.6%  
Employees  3 3 3 3 3  
Employee growth %  50.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,519 1,593 1,408 1,854 1,644  
Balance sheet change%  -8.2% 4.9% -11.6% 31.7% -11.3%  
Added value  -226.9 135.1 29.0 272.9 62.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -46 -18 74 -59 124  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -20.3% 7.9% 0.3% 13.3% 1.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -15.8% 9.0% 0.3% 15.6% 2.6%  
ROI %  -22.5% 14.0% 0.4% 25.6% 4.4%  
ROE %  -18.4% 9.9% -2.8% 16.5% -0.1%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  65.6% 65.3% 66.9% 56.6% 60.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  424.8% -757.5% -2,986.1% -508.2% -1,614.6%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  2.5 2.5 2.3 2.0 1.9  
Current Ratio  2.7 2.7 2.7 2.2 2.1  
Cash and cash equivalent  963.8 1,023.4 866.5 1,411.4 1,005.7  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  655.8 670.5 517.5 647.9 395.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  -76 45 10 91 21  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -76 45 10 93 21  
EBIT / employee  -83 38 1 83 6  
Net earnings / employee  -68 33 -9 55 -0